-
3q29 Microdeletion Syndrome
Wikipedia
Archived from the original on 2013-01-05. ^ Ballif BC, Theisen A, Coppinger J, Gowans GC, Hersh JH, Madan-Khetarpal S, Schmidt KR, Tervo R, Escobar LF, Friedrich CA, McDonald M, Campbell L, Ming JE, Zackai EH, Bejjani BA, Shaffer LG (2008). ... Eur J Med Genet . 53 (6): 415–8. doi : 10.1016/j.ejmg.2010.08.009 . PMID 20832509 . ^ Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC, Sobreira NL, Valle D, Rudd MK, Satten G, Cutler DJ, Pulver AE, Warren ST (August 2010).
-
Alzheimer Disease 2
Omim
The memory phenotype was almost exclusively observed in homozygous E4 carriers. Borroni et al. (2007) also reported an association between the memory phenotype of AD and presence of the E4 allele. ... Wolk et al. (2010) compared the phenotypes of 67 AD patients carrying at least 1 APOE E4 allele to 24 AD patients without an E4 allele. ... Molecular Genetics Corder et al. (1993) found that the risk for late-onset AD increased from 20 to 90% and mean age of onset decreased from 84 to 68 years with increasing number of APOE*E4 alleles (107741.0016) in 42 families with late-onset AD. ... Homozygosity for APOE*E4 was virtually sufficient alone to cause AD by age 80. Bray et al. (2004) applied highly quantitative measures of allele discrimination to cortical RNA from individuals heterozygous for the APOE E2, E3, and E4 alleles. A small, but significant, increase in the expression of E4 allele was observed relative to that of the E3 and E2 alleles (P less than 0.0001).TOMM40, TREM2, ABCA7, APP, APOE, PSEN2, PSEN1, MAPT, SORL1, PRNP, CASP3, BACE1, GSK3B, NCSTN, IDE, IL1B, HFE, A2M, ACE, DHCR24, BIN1, ESR1, ADAM10, ADAMTS1, PGRMC1, VEGFA, ARC, CYP46A1, SLC30A4, VSNL1, PICALM, HMOX1, HLA-DRB5, IGF1R, IGF1, INPP5D, IGF2, MPO, NPY, NOS3, PLAU, PLCG2, PPARG, RELN, MTHFR, PYY, NECTIN2, SLC2A4, IGF2R, SOD2, MAOB, TF, LEP, TFAM, INSR, INS, TNF, TPI1, EPHA1, F2, ENO1, CR1, CASS4, ATP5F1A, CLU, CHRNB2, CHRNA7, MIR766, CD33, IQCK, EIF2S1, MIR505, APOC1, CALM1, MIR100, MIR146A, BDNF, BCL2, MIR375, MIR296, BCHE, MIR708, TPP1, SLC30A6, SNAR-I, DPYSL2, ACHE, CD2AP, GAPDHS, PCDH11X, CYP2D6, MIR4467, CRH, MIR3622B, BAX, AMFR, ABI3, CST3, MS4A4A, WWOX, BRCA2, FANCD2, TFF1, TAS2R64P, CTNNB1, SUCLA2, SNCA, CTSD, RNR2, NEFL, TAS2R62P, SOD1, ITPR3, ITPR2, ITPR1, FLAD1, PSENEN, TP53, CDK5R1, EIF2AK3, UBQLN1, ALG3, PIK3CG, PIK3CA, PIK3CD, SERPINA3, PIK3CB, DOCK3, APLP1, OGDH, CREB1, NOTCH1, CASP6, NGF, CCND1, FOS, DLX4, DLG4, DDIT3, RABGEF1, PEBP1, PYCARD, DAPK2, KCNIP3, CTSB, CSF2, CRMP1, CTSG, EHMT2, ENO2, ERBB4, TMED10, TERF2IP, PTK2B, FCN2, PTGES3, FGF2, ACKR1, DNM1L, SDC3, G6PD, GCHFR, ITM2B, CREBBP, MAP3K8, TRPM7, ADI1, MTCO2P12, UPK3B, ACTB, AKT1, AKT2, ANXA1, APBB1, DNLZ, STS, MIR34A, BRCA1, MIR137, C5AR1, DDR1, CAMK4, TMED10P1, MPEG1, C9orf72, ESCO1, CDCA5, PRRT2, MAP1LC3B, CAT, EHMT1, CNR2, SPPL2B, RAB9A, NRXN3, GFAP, SYNJ1, SERPINB5, CD99, MME, MNAT1, CCL2, RRAS, RPS27, RPS21, RAP1A, PYCR1, COX2, PTS, PTGS2, MTHFD1, MMUT, NCAM1, NFIA, NFIB, MAPK8, MAPK3, PRKCB, PRKCA, PPBP, MED1, NFIC, PPARA, NFIX, PKD1, NOTCH3, NRGN, MEOX2, MEF2A, SPRR2A, TTC3, GRIN2A, DENR, GRIN2B, RAB7A, LRP8, HPRT1, HSP90AA1, VIM, IDUA, UTRN, SUMO1, UBE2I, TTK, TPT1, SULT1E1, IL1A, IL6, IL12A, TSPAN6, TIE1, TGFB1, TG, KNG1, LAMC2, LGALS3, TERT, TERC, STIM1, H3P17
-
Hyperlipoproteinemia, Type Iii
Omim
Although nearly every type III hyperlipoproteinemic person has the E2/E2 phenotype, 95 to 99% of persons with this phenotype do not have type III HLP nor do they have elevated plasma cholesterol levels. ... Obesity, diabetes, and age are associated with increased hepatic synthesis of VLDL and/or cholesterol; occurrence of type III in E2/E2 persons with these factors may be explained thereby. ... All E2 homozygotes reached the target serum LDL level, compared to 32% of E4 homozygotes who did not (p = 5.3 x 10(-5)). ... Smit et al. (1987) described 3 out of 41 Dutch dysbetalipoproteinemic patients who were apparent E3/E2 heterozygotes rather than the usual E2/E2 homozygotes. ... Smit et al. (1990) showed that these 3 unrelated patients were heterozygous for E2(K146Q; 107741.0011). Susceptibility to Coronary Artery Disease Eto et al. (1989) presented data from Japan indicating that both the E2 allele and the E4 allele are associated with an increased risk of ischemic heart disease as compared with the E3 allele.
-
Postoperative Residual Curarization
Wikipedia
New England Journal of Medicine . 378 (4): e6. doi : 10.1056/nejmvcm1603741 . ISSN 0028-4793 . ... "Advances in Neurobiology of the Neuromuscular Junction: Implications for the Anesthesiologist". Anesthesiology . 96 (1): 202–231. doi : 10.1097/00000542-200201000-00035 . ... S2CID 9670756 . ^ Bhananker SM, Treggiari MM, Sellers BA, Cain KC, Ramaiah R, Thilen SR (October 2015). ... "Efficacy of Tactile-guided Reversal from Cisatracurium-induced Neuromuscular Block". Anesthesiology . 96 (1): 45–50. doi : 10.1097/00000542-200201000-00013 . PMID 11753000 . ^ Kopman AF, Zank LM, Ng J, Neuman GG (January 2004).
-
Trichophagia
Wikipedia
"Fatal case of Rapunzel syndrome in neglected child". Forensic Sci. Int . 190 (1–3): e5–7. doi : 10.1016/j.forsciint.2009.05.008 .
-
Wilms' Tumor
Wikipedia
Treatment/prognosis [ edit ] The overall 5-year survival is estimated to be approximately 90%, [19] [20] but for individuals the prognosis is highly dependent on individual staging and treatment . ... Stage [23] Histopathology [23] 4 Year relapse-free survival (RFS) or event-free survival (EFS) [23] 4 Year overall survival (OS) [23] Treatment [23] Stage I [23] Favorable histology in children younger than 24 months or tumor weight less than 550g 85% 98% Surgery only (should be done only within the context of a clinical trial) Favorable histology in children older than 24 months or tumor weight more than 550g 94% RFS 98% Nephrectomy + lymph node sampling followed by regimen EE-4A Diffuse anaplastic 68% EFS 80% Nephrectomy + lymph node sampling followed by regimen EE-4A and radiotherapy Stage II [23] Favorable histology 86% RFS 98% Nephrectomy + lymph node sampling followed by regimen EE-4A Focal anaplastic 80% EFS 80% Nephrectomy + lymph node sampling followed by abdominal radiotherapy and regimen DD-4A Diffuse anaplastic 83% EFS 82% Nephrectomy + lymph node sampling followed by abdominal radiotherapy and regimen I Stage III [23] Favorable histology 87% RFS 94% Nephrectomy + lymph node sampling followed by abdominal radiotherapy and regimen DD-4A Focal anaplastic 88% RFS 100% (8 people in study) Nephrectomy + lymph node sampling followed by abdominal radiotherapy and regimen DD-4A Focal anaplastic (preoperative treatment) 71% RFS 71% Preoperative treatment with regimen DD-4A followed by nephrectomy + lymph node sampling and abdominal radiotherapy Diffuse anaplastic 46% EFS 53% Preoperative treatment with regimen I followed by nephrectomy + lymph node sampling and abdominal radiotherapy Diffuse anaplastic 65% EFS 67% Immediate nephrectomy + lymph node sampling followed by abdominal radiotherapy and regimen I Stage IV [23] Favorable histology 76% RFS 86% Nephrectomy + lymph node sampling, followed by abdominal radiotherapy, bilateral pulmonary radiotherapy, and regimen DD-4A Focal anaplastic 61% EFS 72% Nephrectomy + lymph node sampling, followed by abdominal radiotherapy, bilateral pulmonary radiotherapy, and regimen DD-4A Diffuse anaplastic 33% EFS 33% Immediate nephrectomy + lymph node sampling followed by abdominal radiotherapy, whole-lung radiotherapy, and regimen I Diffuse anaplastic (preoperative treatment) 31% EFS 44% Preoperative treatment with regimen I followed by nephrectomy + lymph node sampling followed by abdominal radiotherapy, whole-lung radiotherapy Stage V [23] Overall 61% EFS 80% Favorable histology 65% 87% Preoperative treatment with regimen DD-4A , followed by nephron sparing surgery or nephrecomy, staging of tumors, and chemotherapy and/or radiotherapy based on pathology and staging Focal anaplastic 76% 88% Preoperative treatment with regimen DD-4A , followed by nephron sparing surgery or nephrecomy, staging of tumors, and chemotherapy and/or radiotherapy based on pathology and staging Diffuse anaplastic 25% 42% Preoperative treatment with regimen DD-4A , followed by nephron sparing surgery or nephrecomy, staging of tumors, and chemotherapy and/or radiotherapy based on pathology and staging In case of relapse of Wilms' tumor, the 4-year survival rate for children with a standard-risk has been estimated to be 80%. [24] Epidemiology [ edit ] Wilms tumor is the most common malignant renal tumor in children. [25] There are a number of rare genetic syndromes that have been linked to an increased risk of developing Wilms Tumor. [26] Screening guidelines vary between countries; however health care professionals are recommending regular ultrasound screening for people with associated genetic syndromes. [26] Wilms' tumor affects approximately one person per 10,000 worldwide before the age of 15 years. [27] People of African descent may have slightly higher rates of Wilms' tumor. [27] The peak age of Wilms' tumor is 3 to 4 years and most cases occur before the age of 10 years. [28] A genetic predisposition to Wilms' tumor in individuals with aniridia has been established, due to deletions in the p13 band on chromosome 11. [29] History [ edit ] Dr. ... Cell . 60 (3): 509–20. doi : 10.1016/0092-8674(90)90601-A . PMID 2154335 . S2CID 29092372 . ^ Huff V (October 1998). ... PMID 26304882 . ^ Coorens THH, Treger TD, Al-Saadi R, Moore L, Tran MGB, Mitchell TJ, Tugnait S, Thevanesan C, Young MD, Oliver TRW, Oostveen M, Collord G, Tarpey PS, Cagan A, Hooks Y, Brougham M, Reynolds BC, Barone G, Anderson J, Jorgensen M, Burke GAA, Visser J, Nicholson JC, Smeulders N, Mushtaq I, Stewart GD, Campbell PJ, Wedge DC, Martincorena I, Rampling D, Hook L, Warren AY, Coleman N, Chowdhury T, Sebire N, Drost J, Saeb-Parsy K, Stratton MR, Straathof K, Pritchard-Jones K, Behjati S (2019) Embryonal precursors of Wilms tumor. ... Medical and Pediatric Oncology . 21 (3): 172–81. doi : 10.1002/mpo.2950210305 . PMID 7680412 . ^ Breslow NE, Beckwith JB, Perlman EJ, Reeve AE (September 2006).GPC3, WT1, BRCA2, DICER1, H19, TRIP13, TRIM28, REST, VHL, TP53, IGF2, CDKN1C, DIS3L2, POU6F2, AMER1, MYCN, GPC4, CTNNB1, SIX2, CTCF, DROSHA, DGCR8, ASXL1, MLLT1, SIX1, XPO5, GLIPR1, COL6A3, ARID1A, BCORL1, PALB2, BCOR, NONO, MAX, PAX2, TTN, MAP3K4, LIN28A, BMP7, PAX6, PIK3CA, NR5A1, SRY, KCNQ1OT1, PTCH1, NR0B1, KCNQ1, WWOX, ZFPM2, BUB1B, TRIM37, H19-ICR, CDC73, MAP3K1, CHEK2, NHS, DLG2, SOX9, HDAC4, VAMP7, ERBB2, TCN2, EWSR1, EXT2, HLA-A, PAX8, FLT3, GATA4, CEP57, ABL1, BUB3, WT1-AS, PCSK9, SETBP1, BCL2, NSD1, ALX4, CAT, DMRT3, DEL11P13, BUB1, PHF21A, CD34, LINC01194, ABCB1, KTWS, IGF1R, WT4, NCAM1, EGFR, NPM1, MIR193A, KRAS, IGF1, STAT3, TBC1D9, RUNX1T1, VEGFA, EGR1, PTEN, BRCA1, MTTP, HRAS, KIT, BCR, AKT1, CITED1, BDNF, VIM, AR, DES, HSPA4, TP73, EMG1, PIK3CB, PODXL, PIK3CD, SYNPO, CCN2, MDK, KMT2A, PIK3CG, RUNX1, NPHS2, IFNG, ESR1, APC, REN, PRDM2, RPL10, RARA, RBBP7, RET, PLXNA1, STIM1, NES, CDH1, HTC2, PMEL, RRM1, PTGS2, MYH11, CDKN2A, HGF, PHOX2B, CCN3, CYP19A1, RASSF1, ARHGAP24, MUC16, AMH, TOP2A, MEG3, SLC22A18, NFE2L2, NRAS, IH, PCNA, DEL11P13, PRTN3, NOTCH1, MIR483, PDGFA, MAPK3, ABCB4, PRKCA, LINC00673, MIR361, PRAME, MIR21, MVP, TP63, PROM1, MIB1, HACE1, MAPK8IP1, CTR9, SALL4, EFS, RPE65, CIB2, TET2, WNT4, CKAP4, IGF2-AS, IL22, CD274, RECK, FZD7, HMGA2, BAALC, SCT, ACTN4, MIR15A, MIR140, STAT1, LIN28B, MAP3K7, TRBV20OR9-2, TGFA, TGFB1, NKX2-1, NR2C2, UVRAG, PPP1R2C, WT2, TERT, H3P10, LMO1, CASP8, GATA1, GLI1, CCND1, CEBPA, FSHB, LMX1B, SMAD4, CRABP2, CEACAM5, BRAF, CCN1, CALB2, EZH2, ALDH1A1, HIF1A, CDH11, ABCC1, MTHFR, CD14, E2F3, AFP, GATA2, JAG1, CDKN2B, AATF, BBS9, LAMP3, HAVCR1, ELP4, PAF1, FBXW8, CDK4, TES, CRLS1, CD151, IBTK, CD59, CD44, ADGRE5, HPGDS, NCKIPSD, SGSM3, HTRA2, PIAS4, CDH13, CTNNA3, CDX1, ADGRE2, NOX4, SYCP3, KRT20, SOSTDC1, SLC38A2, CDKN3, PLCE1, KLF15, MUC4, NIPBL, RAB40B, SMR3B, FRS2, BRINP1, DCC, DDX1, DNASE1, DNMT3A, BASP1, NDC80, ATN1, IRX5, SPRY1, MSLN, HDAC5, HDAC6, EGR2, RNF40, PIEZO1, EGR3, BLCAP, CYP27B1, CD2AP, CTNNA1, CHRM3, QPRT, FBXW7, CHUK, COL4A1, DTX4, ATG4B, COL11A2, NCOA6, DKK1, PHLDA1, CRP, KLHL2, USP18, CSF2, CSF3, PTP4A3, CORO1A, CSF3R, QRSL1, CBFB, CD40LG, ALK, ANXA5, MIR370, MIAT, MIR23A, MIR215, APRT, MIR204, MIR203A, MIR200C, MIR19B1, MIR199B, MIR195, KLK3, MIR192, MIR16-1, FASLG, MIR155, MIR144, MIR141, MIR429, SNHG6, PCDHA@, LINC00273, H3P47, LINP1, ACVR2B, ADAR, APOBEC3A_B, PARP1, SOX21-AS1, MIR1180, MIR1270, CD24, LINC00893, MIR190B, RNA18SN5, MIR613, MIR600, MIR590, MIR572, MIR562, MIR539, AREG, MIR130B, ATF3, C17orf97, BMPR1A, CMIP, WLS, TSPO, CA9, CALCA, IRX3, MARCKSL1, CALR, CASP3, IL21, RUNX3, WFDC1, SEMA6A, ENO2, CD80, INTS2, CD38, PNPLA2, PRAM1, DLGAP1-AS2, C19orf48, CLYBL, BAK1, PWAR4, SOX2-OT, LUZP2, BARD1, NAPSB, AMER2, APOBEC3A, BCL2A1, KRT88P, OPN1SW, OSR1, BCS1L, WTIP, SAT2, BMP2, MTDH, LINC00473, EPHA2, KLF4, RGS6, IL17A, RBP2, INSR, RB1, ITGAX, RAP1A, PTPRC, PTN, JAK2, PTH, KDR, KRT7, LAMB2, PRM1, LHCGR, LHX1, PTPA, PPP2R1A, PPBP, PON1, INS, IL15, LMO2, RFC1, SLC5A5, SMTN, SLC2A3, SLC2A1, SIX3, IFI16, STIL, IFNB1, SHMT1, SRSF1, IGF2R, SET, SALL1, SALL2, S100A4, IL2, IL4, IL6, RGS4, PMS2, PLCG2, RIN1, SERPINE1, OGG1, ROR1, MKI67, MLH1, NPHS1, NPHP1, MPZ, NPY, MRC1, NNAT, NKX6-1, MSH3, NGFR, NGF, MSX1, NF2, NEFL, NAP1L4, MYOD1, MIP, PAWR, PLAG1, CD99, PKHD1, PIK3R1, LSAMP, SMAD2, PHF2, PHB, MCM2, MDM4, PGR, PFN1, SERPINF1, PECAM1, PDGFRB, MEIS1, MET, PBX2, MFAP1, PAX5, PAX3, SLC8A1, SLC19A1, SNAI2, FEN1, FZD1, BAP1, FGF8, MIA, FH, WT3, FLI1, FXR1, RASSF7, DEK, FZD5, CXCR4, FLII, FN1, ZNF224, ZBTB16, FUT4, GABPA, WNT5A, FGF3, MKNK1, SMARCB1, FANCB, VPS4B, EPHB2, ERCC2, MUC1, S1PR2, ETS1, FIBP, ARHGEF1, F2RL3, RTL8C, EYA1, CCNA1, HDAC3, CFLAR, DLK1, RNMT, MBTPS1, BECN1, AKR1C3, GAPDH, VDR, GDNF, TTK, HNRNPL, HNF1B, HNF1A, TBXA2R, TAL1, HOXB4, HOXD10, STK11, HSPA1A, HSPA1B, HSP90AA1, HSP90AA2P, SRPK1, SRF, SRD5A2, SPP1, SPI1, IRF8, SOD1, HLA-DQA1, TERF1, TERF2, TSPAN7, TTF1, PHLDA2, TSG101, TSC2, GLRA2, MSH6, GUSB, HBB, HCRTR1, HLA-C, TIMP4, TIMP1, THY1, THOP1, THBS1, THBD, TH, HDAC1, SFRP1
-
Bronchopulmonary Dysplasia
Wikipedia
. ^ Ehrenkranz, RA; Walsh, MC; Vohr, BR; Jobe, AH; Wright, LL; Fanaroff, AA; Wrage, LA; Poole, K; National Institutes of Child Health and Human Development Neonatal Research, Network (Dec 2005). ... American Journal of Respiratory and Critical Care Medicine . 199 (3): e5–e23. doi : 10.1164/rccm.201812-2276ST . PMC 6802853 . PMID 30707039 . ^ Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, et al. (2007).IL1B, TXN, POSTN, HIF1A, CAT, EPAS1, EDN1, CASP9, CASP8, CASP3, BID, BAX, CXCL1, TP53, SPOCK2, NBL1, CTNNA3, AGBL1, IL6, BDNF, VEGFA, IL1RAPL1, AGBL1-AS1, TGFB1, DMD, MICOS10-NBL1, ACE, NFE2L2, TNF, ACTB, FGF10, SLC6A4, SFTPB, ANK3, PPARG, ERBB4, OPN1LW, CCN2, COMT, IL10, IL1A, FN1, HMOX1, SFTPA1, SFTPD, AHR, IL1RN, ELN, TIMP1, FGF7, GABPA, MMP9, CYP1A1, GAD1, EPO, GSTT1, GSTM1, NOS3, DISC1, CTNNB1, SFTPC, P2RX7, REN, SOD3, CXCL12, SCGB1A1, CACNA1C, P2RX5, TNFAIP6, IL18, IL17A, TGM2, HPGDS, SGSM3, SELL, TGFA, SLC6A3, CCL2, SOD2, IGF1, IFNG, TNC, TLR4, NRG1, HDAC2, TXNRD1, TPH1, CCL24, KDR, P2RX4, MMP2, P2RX3, P2RX1, NR3C1, P2RY1, P2RY2, PC, PDGFRA, MTHFR, COX2, PDGFRB, POMC, BRD1, MSC, P2RX6, MBL2, LOX, PTGS2, LLGL1, TIMP2, P2RX2, PRPH2, SIRT1, TST, TLR5, ZNF804A, NQO1, MIR34A, NPSR1, FGFR2, MIR17HG, FKBP5, TPH2, ELANE, CRISPLD2, GABRB2, DGKH, DPYSL2, DNMT1, MIR206, SFTPA2, CHRNA7, AKT1, GRK3, CTSG, CRP, CENPJ, CRHR1, P2RX5-TAX1BP3, DDIT3, NLRP3, MIR21, AIMP1, MIR29B2, CLOCK, MIR29B1, ARHGEF7, MIR17, ZBED4, CDK2AP2, IL18BP, MIR30A, PLOD3, MIR219A1, FHL5, MIRLET7C, IPO13, LPAR2, LRPPRC, VAPA, MIR214, SYBU, SYNJ1, SOD2-OT1, WASH6P, SUMO1, MIR421, ZGLP1, MIR876, TRAF1, TAF9BP2, PER2, WASHC1, LINC01672, RN7SL263P, TSPAN8, MTCO2P12, H3P8, VASP, VDR, POTEM, MIR489, MIR431, XBP1, CXCR4, SLC14A2, BDNF-AS, PLF, MIR335, MAD1L1, POTEKP, MDD1, PLA2G10, IL18R1, CCN5, TLR6, GPNMB, CEP85L, IL33, LAMTOR2, MAP1LC3B, LMAN2L, EHMT1, MCPH1, ZDHHC8, MPPE1, F11R, SHANK1, ASCC1, ADIPOR1, RMDN1, PINK1, LEF1, CLDN18, ETNPPL, NPAS3, NIF3L1, MZB1, NRN1, PTBP2, SF3B6, ZNF410, TREM1, DLL4, UGT1A1, ACKR3, DYM, RMDN3, MIXL1, ESAM, MALAT1, BOC, GSTK1, ACTBL2, CACNG2, CHDH, CAP2, PDLIM5, HCA1, CXCR6, PDE10A, SUB1, KANK4, EML5, RAB40B, RIPK3, RMDN2, RPP14, SLCO6A1, ACOT7, SHANK2, SCGB3A2, TIRAP, SYNE1, DDAH2, DDAH1, IL17F, CACNA2D4, EML2, TENM4, INTU, SERPINA3, MAPK3, TLR2, TIMP3, FOXF2, FOXF1, FGFR4, F3, F2RL1, EZH2, ETS1, EPHA1, ENG, SERPINB1, EGFR, EDNRA, LPAR1, DUSP5, DUSP1, DRD4, DDT, FOXM1, FLNA, FPR1, GNAS, GRP, GRIK2, GRN, GPR42, MCHR1, UTS2R, GPC1, GLP1R, G6PD, GFAP, GDF2, GCH1, GCG, GC, GATA6, GAD2, DAG1, CYP2B6, CYP1B1, AGT, ATF4, ARG1, APOE, ANXA1, ANGPT1, ALB, AGTR1, ADRA2B, BMP7, ADRA1A, ADCYAP1, ADCY2, ADA, ACVRL1, ACTG2, ACTG1, BCL2, BMPR2, CSF3, CDKN2A, CRYZ, CRH, CMKLR1, CLU, CHRNA2, CHRM2, CFL1, CDKN1A, BPI, CD44, CD40, CD34, CAMK2A, CALB2, CACNA1E, BRS3, GSK3B, GSTA6P, GSTP1, RELN, SCN8A, SCN4B, S100A9, RARA, PVALB, PTBP1, PRTN3, PRSS2, CCL18, ABCA3, MAPK1, PLOD2, PLG, PLCG1, PLA2G2A, PFN1, CCL13, SELP, PCNA, SST, THY1, THBS1, TH, TAC1, VAMP7, STAT3, SSTR4, SOX4, SIPA1, SOD1, SUMO2, SMARCA4, SLC18A2, SLC18A1, SLC6A2, SLC1A2, PECAM1, SERPINE1, GSTZ1, ID2, KCNQ2, IRAK1, IMPA2, IL6ST, IL6R, IL4, CCN1, HTR2C, KIT, HTR2A, HTR1B, HTR1A, HSP90AA1, HMGB1, HLA-A, HDAC1, KCNQ3, LCT, OTSC1, MPO, NR4A2, CCN3, NOTCH3, NM, NGF, NFKBIA, NFKB1, MMP16, LDHA, KMT2A, MIF, LOXL2, LOXL1, FADS1, LGALS1, LEP, H3P40
-
Arthrofibrosis
Wikipedia
The common pathway for the development of arthrofibrosis (AF) is excessive collagen fibril deposition in and around the knee. ... One study's definition is a total range of motion (ROM) <90 degrees constitutes AF, another definition is flexion contracture >10 degrees, or inability to flex the knee >100 degrees. ... "Adhesive capsulitis of the wrist: arthrographic diagnosis". Radiology . 167 (1): 187–90. doi : 10.1148/radiology.167.1.3347720 . ... "Arthroscopic treatment of the arthrofibrotic knee". Arthroscopy . 20 Suppl 2: 187–94. doi : 10.1016/j.arthro.2004.04.036 . ... The American Journal of Sports Medicine . 22 (2): 184–91. doi : 10.1177/036354659402200206 .
-
Serotonin Syndrome
Wikipedia
. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be Boyer EW, Shannon M (March 2005). ... "The clinical toxicology of metamfetamine" . Clin Toxicol . 48 (7): 675–94. doi : 10.3109/15563650.2010.516752 . ... "Drug-induced serotonin syndrome: a review". Expert Opin Drug Saf . 7 (5): 587–96. doi : 10.1517/14740338.7.5.587 . ... Eur Arch Psychiatry Clin Neurosci . 248 (2): 96–103. doi : 10.1007/s004060050024 . ... Progress in Brain Research. 162 . pp. 81–104. doi : 10.1016/S0079-6123(06)62006-2 .
-
Brunner Syndrome
Wikipedia
. ^ Online Mendelian Inheritance in Man (OMIM): 300615 ^ Brunner HG; Nelen MR; van Zandvoort P; Abeling NGGM; van Gennip AH; Wolters EC; Kuiper MA; Ropers HH; van Oost BA (June 1993). "X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism" . ... PMID 23871722 . ^ a b c d Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA (October 1993). "Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A". Science . 262 (5133): 578–80. Bibcode : 1993Sci...262..578B . doi : 10.1126/science.8211186 . ... "Specification of the phenotype required for men with monoamine oxidase type A deficiency". Hum. Genet . 96 (3): 372–6. doi : 10.1007/BF00210430 . ... External links [ edit ] Classification D ICD - 10 : E70.8 OMIM : 300615 MeSH : C563156 C563156, C563156 DiseasesDB : 32391 External resources Orphanet : 3057 v t e X-linked disorders X-linked recessive Immune Chronic granulomatous disease (CYBB) Wiskott–Aldrich syndrome X-linked severe combined immunodeficiency X-linked agammaglobulinemia Hyper-IgM syndrome type 1 IPEX X-linked lymphoproliferative disease Properdin deficiency Hematologic Haemophilia A Haemophilia B X-linked sideroblastic anemia Endocrine Androgen insensitivity syndrome / Spinal and bulbar muscular atrophy KAL1 Kallmann syndrome X-linked adrenal hypoplasia congenita Metabolic Amino acid : Ornithine transcarbamylase deficiency Oculocerebrorenal syndrome Dyslipidemia : Adrenoleukodystrophy Carbohydrate metabolism : Glucose-6-phosphate dehydrogenase deficiency Pyruvate dehydrogenase deficiency Danon disease/glycogen storage disease Type IIb Lipid storage disorder : Fabry's disease Mucopolysaccharidosis : Hunter syndrome Purine–pyrimidine metabolism : Lesch–Nyhan syndrome Mineral : Menkes disease / Occipital horn syndrome Nervous system X-linked intellectual disability : Coffin–Lowry syndrome MASA syndrome Alpha-thalassemia mental retardation syndrome Siderius X-linked mental retardation syndrome Eye disorders: Color blindness (red and green, but not blue) Ocular albinism ( 1 ) Norrie disease Choroideremia Other: Charcot–Marie–Tooth disease (CMTX2-3) Pelizaeus–Merzbacher disease SMAX2 Skin and related tissue Dyskeratosis congenita Hypohidrotic ectodermal dysplasia (EDA) X-linked ichthyosis X-linked endothelial corneal dystrophy Neuromuscular Becker's muscular dystrophy / Duchenne Centronuclear myopathy (MTM1) Conradi–Hünermann syndrome Emery–Dreifuss muscular dystrophy 1 Urologic Alport syndrome Dent's disease X-linked nephrogenic diabetes insipidus Bone / tooth AMELX Amelogenesis imperfecta No primary system Barth syndrome McLeod syndrome Smith–Fineman–Myers syndrome Simpson–Golabi–Behmel syndrome Mohr–Tranebjærg syndrome Nasodigitoacoustic syndrome X-linked dominant X-linked hypophosphatemia Focal dermal hypoplasia Fragile X syndrome Aicardi syndrome Incontinentia pigmenti Rett syndrome CHILD syndrome Lujan–Fryns syndrome Orofaciodigital syndrome 1 Craniofrontonasal dysplasia v t e Inborn error of amino acid metabolism K → acetyl-CoA Lysine /straight chain Glutaric acidemia type 1 type 2 Hyperlysinemia Pipecolic acidemia Saccharopinuria Leucine 3-hydroxy-3-methylglutaryl-CoA lyase deficiency 3-Methylcrotonyl-CoA carboxylase deficiency 3-Methylglutaconic aciduria 1 Isovaleric acidemia Maple syrup urine disease Tryptophan Hypertryptophanemia G G→ pyruvate → citrate Glycine D-Glyceric acidemia Glutathione synthetase deficiency Sarcosinemia Glycine → Creatine : GAMT deficiency Glycine encephalopathy G→ glutamate → α-ketoglutarate Histidine Carnosinemia Histidinemia Urocanic aciduria Proline Hyperprolinemia Prolidase deficiency Glutamate / glutamine SSADHD G→ propionyl-CoA → succinyl-CoA Valine Hypervalinemia Isobutyryl-CoA dehydrogenase deficiency Maple syrup urine disease Isoleucine 2-Methylbutyryl-CoA dehydrogenase deficiency Beta-ketothiolase deficiency Maple syrup urine disease Methionine Cystathioninuria Homocystinuria Hypermethioninemia General BC / OA Methylmalonic acidemia Methylmalonyl-CoA mutase deficiency Propionic acidemia G→ fumarate Phenylalanine / tyrosine Phenylketonuria 6-Pyruvoyltetrahydropterin synthase deficiency Tetrahydrobiopterin deficiency Tyrosinemia Alkaptonuria / Ochronosis Tyrosinemia type I Tyrosinemia type II Tyrosinemia type III / Hawkinsinuria Tyrosine → Melanin Albinism : Ocular albinism ( 1 ) Oculocutaneous albinism ( Hermansky–Pudlak syndrome ) Waardenburg syndrome Tyrosine → Norepinephrine Dopamine beta hydroxylase deficiency reverse: Brunner syndrome G→ oxaloacetate Urea cycle / Hyperammonemia ( arginine aspartate ) Argininemia Argininosuccinic aciduria Carbamoyl phosphate synthetase I deficiency Citrullinemia N-Acetylglutamate synthase deficiency Ornithine transcarbamylase deficiency / translocase deficiency Transport / IE of RTT Solute carrier family : Cystinuria Hartnup disease Iminoglycinuria Lysinuric protein intolerance Fanconi syndrome : Oculocerebrorenal syndrome Cystinosis Other 2-Hydroxyglutaric aciduria Aminoacylase 1 deficiency Ethylmalonic encephalopathy Fumarase deficiency Trimethylaminuria
-
Oneiroid Syndrome
Wikipedia
Общая психопатология: Учебное пособие для студентов высших учебных заведений [ General psychopathology: Textbook for students of higher educational institutions ] (in Russian). Moscow: Academia. pp. 80–82. ISBN 5-7695-0838-8 . ^ a b Kaptsan, A; Miodownick, C; Lerner, V (2000). ... ISBN 978-0-19-517668-1 . ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab Жариков, Н. М.; Тюльпин, Ю. Г. (2002). ... Journal of Psychiatry & Neuroscience . Joule Inc. 35 (4): E5–6. doi : 10.1503/jpn.100087 . ISSN 1180-4882 .
-
Postural Orthostatic Tachycardia Syndrome
Wikipedia
In one survey of 138 POTS patients, brain fog was defined as “forgetful” (91%), “difficulty thinking” (89%), and “difficulty focusing” (88%). ... Ivabradine [83] [84] [99] [100] alpha-2 adrenergic receptor agonist Decreases blood pressure and sympathetic nerve traffic. ... S2CID 11628648 . ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag Mathias CJ, Low DA, Iodice V, Owens AP, Kirbis M, Grahame R (December 2011). ... Neuroscience and Biobehavioral Reviews . 90 : 174–183. doi : 10.1016/j.neubiorev.2018.04.017 . ... Indian Pacing and Electrophysiology Journal . 6 (2): 84–99. PMC 1501099 . PMID 16943900 . ^ Kavi L, Gammage MD, Grubb BP, Karabin BL (June 2012).
-
Tethered Spinal Cord Syndrome
Wikipedia
Thieme Medical Publishers, Inc. p. 90. ISBN 978-1-60406-241-0 . The diagnosis of TCS is primarily based on neurological and musculoskeletal signs and symptoms. ... "Pediatric urodynamics: basic concepts for the neurosurgeon" . Neurosurg Focus . 23 (2): E8. doi : 10.3171/FOC-07/08/E8 . PMID 17961012 . ^ Hadley, H. ... "Management of Recurrent Adult Tethered Cord Syndrome". Neurosurgical Focus . 29 (1): E5. doi : 10.3171/2010.3.FOCUS1073 .MTHFR, PAX3, PDGFRA, VANGL2, PCMT1, CFL1, PON1, CHKA, CCL2, TXN2, PCYT1A, FGFR2, RNF2, SUZ12, MTRR, MTR, MTHFD1, BRCA1, SLC25A1, PTCH1, DLL4, FLI1, FANCL, RFWD3, FANCI, TRIM36, FANCC, SUFU, PSAT1, UBE2T, PHGDH, FANCF, HAAO, MEOX1, PTCH2, MAD2L2, LMX1B, RBM8A, BMS1, KIF22, FANCG, GDF3, FANCB, CREBBP, BRIP1, BRCA2, RAD51C, SLX4, RAD51, PALB2, FANCE, RMRP, PORCN, XRCC2, GDF6, SLC25A19, FANCM, ERCC4, FANCA, FANCD2, ZIC2, DHFR, GRHL3, FUZ, BHMT, CELSR1, TYMS, PTK7, CBS, NOS3, LEPR, NAT1, PAX1, PRCP, SLC19A1, TIMP2, CYP26A1, GRHL2, CBSL, AFP, PGPEP1, FOLR1, FOLR2, SCRIB, COMT, BMP1, ZIC1, VSIR, PKD2L1, VANGL1, ANKEF1, CD200R1, PRICKLE2, UCP2, PCSK9, TP53, SLC5A11, SLC39A4, CCDC88A, ALDH1A2, ISYNA1, TGIF1, TRIM26, FZD3, FKBP8, BHMT2, GPR161, CUBN, DVL1P1, FOXN1, ALDH1L1, MTHFD2, TNIP1, NKX2-8, NNMT, TGFB1, SOX3, GCKR, FOSB, FOS, FOLH1, FLT4, GPC5, FGF3, FAP, ERCC2, EPHA4, DVL3, DVL1, DPP4, TRDMT1, SARDH, CSF2, CRABP2, ABCC2, CD38, CASP8, CASP3, BMP4, BDNF, ARSA, APOE, APOB, APEX1, APAF1, ABO, GLI2, GNAS, UTS2R, LAMC2, SLC2A1, SKI, RFC1, PRKCB, PRKCA, NAT2, NGF, MS, CD200, MMP2, LRP6, LMNB1, LEP, JUND, HK1, JUNB, JUN, JARID2, ITPK1, IL18, IL13, IL10, HOXD@, HOXC@, HOXB@, HOXA@, HMOX1, HLA-DRB4, RN7SL263P
-
Atrial Fibrillation, Familial, 1
Omim
Description Atrial fibrillation (AF) is the most common sustained cardiac rhythm disturbance, affecting more than 2 million Americans, with an overall prevalence of 0.89%. ... Twenty-four of the 29 rare variants found in the lone AF patient cohort had previously been studied, with 23 (96%) showing abnormal ion channel function by patch-clamp analysis. Olesen et al. (2014) suggested that rare variants in AF susceptibility genes may play a role in the pathophysiology of AF. ... The association was replicated in 2 independent lone AF cohorts (combined p = 1.83 x 10(-21); odds ratio, 1.52). Ellinor et al. (2010) noted that although KCNN3 is a plausible candidate gene for lone AF, the associated SNPs may lie within or serve as proxies for noncoding regulatory elements that might affect gene expression at considerable distances from their genomic locations.
-
Gout
Wikipedia
Lowering uric acid levels can cure the disease. [8] Treatment of associated health problems is also important. [8] Lifestyle interventions have been poorly studied. [80] It is unclear whether dietary supplements have an effect in people with gout. [82] NSAIDs [ edit ] NSAIDs are the usual first-line treatment for gout. ... Historically, it was referred to as "the king of diseases and the disease of kings" [8] [102] or "rich man's disease". [14] The Ebers papyrus and the Edwin Smith papyrus , (circa 1550 BC) each mention arthritis of the first metacarpophalangeal joint as a distinct type of arthritis. ... PMID 27380294 . ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah Richette P, Bardin T (January 2010). ... "Atypical Triggering at the Wrist due to Intratendinous Infiltration of Tophaceous Gout" . Hand (N Y) . 4 (1): 78–80. doi : 10.1007/s11552-008-9120-4 . ... Rheumatology (Oxford, England) . 40 (10): 1189–90. doi : 10.1093/rheumatology/40.10.1189 .ABCG2, SLC2A9, CD14, IL1B, IL1RN, ALPK1, XDH, CARD8, ALDH16A1, HPRT1, ZNF518B, HNF1B, DARS2, BCAS3, ALX4, RNF115, MACROD1, SEC61A1, NRBP1, A1CF, MLXIPL, TRIM54, MEPE, PRKAG2, SFMBT1, CNTN5, SLC22A11, CARMIL1, RBFOX1, SHLD2, ABCA1, TBL2, FNDC4, SLC17A4, ABCC9, SLC17A2, H2AC5P, BAIAP2, TRIM38, KAT5, SCGN, POLR3C, SLC17A3, SLC22A7, CD160, NXPH4, GPN1, R3HDM2, MLXIP, SLC4A1AP, FSTL4, CUX2, IFT172, FBXO22, ZSCAN31, WNT5B, SLC13A3, TRIM46, LINC02537, RAF1P1, LHFPL3, KRT8P26, OR7E35P, CRIP3, FAM86MP, LINC01460, LINC01405, ALG1L3P, ADPGK-AS1, H2BC2P, MUC22, AADACL2-AS1, CT69, LINC01229, RFX3-AS1, B4GALT1-AS1, PPM1K-DT, RELA-DT, NRXN2-AS1, HNF1A-AS1, NALCN, H2BC1, CLNK, WDR1, INHBE, QRICH2, RNASEH2C, C2orf16, ZNF512, AP5B1, UBE2Q2, SLC22A12, ZNF513, CNIH2, NRG4, NIPAL1, FAM53A, LINC01010, NUDT17, KRTCAP3, SLC16A9, H2AC1, JAZF1, SH2B3, ABCG1, SNX17, ORC4, IGF1R, INHBC, INSR, KCNQ1, LRP6, MAP3K11, MPV17, MUC1, SLC22A18AS, HLF, OVOL1, PDE1C, PDZK1, PFKM, PKD2, ACVR2A, PPM1G, PRKCA, HNF4G, HGF, PRPS1, CYP2E1, ALDH2, ANK1, APOE, ATP1A4, BDKRB2, CFTR, CLCNKB, CYP2C8, EPB42, HFE, FGFR2, FRK, G6PC, SLC37A4, GCKR, GTF3C2, H1-2, H1-6, MAPK6, PPARD, H2BP5, ZMYM6, SPP1, SPTA1, SPTB, ABCC8, SLC5A6, ALDH1A2, PTPRD, HNF1A, TPST1, H4C2, H4C3, H3C2, H2BC4, UMOD, VDR, H2AC4, BAZ1B, BCL7B, NRXN2, PYGM, BABAM2, MAP4K2, RAB27B, RARB, MRPL33, RREB1, ATXN2, SLC22A1, SLC4A1, SLC12A3, SLC17A1, H2AC6, CXCL8, ADIPOQ, CRP, BCL2, CXCL16, NR2C2, MT1B, PRKG2, POMC, S100A9, CCL2, IL33, MTTP, SLC40A1, SIRT1, MAP3K7, IL18, IL6, TGFB1, TNF, HLA-B, IL4
-
Night Eating Syndrome
Wikipedia
"Prophylactic diet: A treatment for night eating syndrome". Hypothesis . 10 (1): e5. ^ a b c d e Young, SN (2007), "How to increase serotonin in the human brain without drugs", J Psychiatry Neurosci , 32 (6): 394–399, PMC 2077351 , PMID 18043762 . ^ O'Reardon J.P.; Stunkard A.J.; Allison K.C. (2004).
-
Renal Tubular Acidosis
Wikipedia
Reabsorption of bicarbonate is typically 80-90% in the proximal tubule and failure of this process leads to decreased systemic buffer and metabolic acidosis . [9] The distal intercalated cells function normally, so the acidemia is less severe than dRTA and the alpha intercalated cells can produce H + to acidify the urine to a pH of less than 5.3. [10] pRTA also has several causes, and may occasionally be present as a solitary defect, but is usually associated with a more generalized dysfunction of the proximal tubular cells called Fanconi syndrome , in which there is also phosphaturia , glycosuria , aminoaciduria, uricosuria, and tubular proteinuria . ... A defect in bicarbonate reabsorption with normal urinary acidification" . Pediatric Research . 1 (2): 81–98. doi : 10.1203/00006450-196703000-00001 . ... Journal of the American Society of Nephrology . 13 (8): 2160–70. doi : 10.1097/01.ASN.0000023430.92674.E5 . PMID 12138150 . ^ de Jong PE, Koomans HA, Weening JJ (2000). ... "Carbonic anhydrase II (CA II) deficiency in Maghrebian patients: evidence for founder effect and genomic recombination at the CA II locus". Human Genetics . 99 (5): 634–7. doi : 10.1007/s004390050419 . ... The Journal of Pediatrics . 8 (4): 489–99. doi : 10.1016/s0022-3476(36)80111-5 . ^ Baines AM, Barelay JA, Cooke WT (1945).SLC4A1, SLC4A4, SLC12A3, FOXI1, ATP6V0A4, CTSB, CYP11B1, ATP6V1B1, CLCNKB, SURF1, NUBPL, KYNU, SCO2, CLDN16, VIPAS39, NDUFAF3, EPG5, COQ2, RMND1, PDSS2, VPS33B, NADK2, NOTCH2, NDUFS2, NDUFB8, CAD, CPT1A, CA2, PDB1, ERBB2, MRGPRF, NT5C1A, CA1, CLCN5, CLCN7, COX16, COX10, EPHA3, ATP6V0A2, BAMBI, SLC26A4, RBFOX2, SLC12A7, NR5A1, GH1, KCNMA1, NR3C2, FGF23, PHA2A, PFKP, PFKM, JAG1
-
Electrolyte Imbalance
Wikipedia
. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj Walls, Ron M.; Hockberger, Robert S.; Gausche-Hill, Marianne (2018). ... Clinics in Perinatology . 41 (3): 575–90. doi : 10.1016/j.clp.2014.05.007 . ... Pediatrics in Review . 23 (11): 371–80. doi : 10.1542/pir.23-11-371 . PMID 12415016 . ... Revista chilena de pediatria (Review). 85 (3): 269–80. doi : 10.4067/S0370-41062014000300002 . ... ISBN 978-0-07-179476-3 . ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag Tintinalli, JE; Stapczynski, J; Ma, O; Yealy, DM; Meckler, GD; Cline, DM (2016).
-
Hereditary Breast And Ovarian Cancer Syndrome
Orphanet
Breast cancer (BC) is the most common cancer in women, accounting for 25% of all new cases of cancer. Most BC cases are sporadic, while 5-10% are estimated to be due to an inherited predisposition. ... The lifetime risk of developing hereditary BC (HBC) and/or OC can reach 80%. Clinical description HBC is not associated with specific phenotypic features. Etiology Autosomal dominant alterations in two genes, BRCA1 and BRCA2 , are likely to account for most familial cases of early-onset BC and/or ovarian cancer (OC), and for 3-4% of all BC. ... Diagnostic methods HBC diagnosis relies upon the following characteristics: increasing numbers of affected family members through the same bloodline (either maternal or paternal), early onset of disease, an excess of bilateral disease, an association with ovarian cancer (at any age), and occurrence of BC in males. Genetic testing confirms the diagnosis and allows better management of people at high risk of developing BC and/or OC.BRCA1, BRCA2, TP53, RAD51C, CHEK2, PALB2, RAD51D, BRIP1, MRE11, BARD1, NBN, PTEN, RAD50, RAD51, ATM, MLH1, ABRAXAS1, RAD51B, RPL21P4, C11orf65, MSH6, MSH2, PMS2, KRT88P, KRAS, PRSS1, BRCA3, MRC1, AR, WT1, SEM1, VHL, PARP1, RASSF7, ALYREF, HOXB13, RNU1-4, OLA1, HSD17B7, BCCIP, EMSY, DHRS11, SLC22A12, HSD17B13, MIR146A, S100A2, PMS1, RB1, FANCC, APRT, CDH1, CDK2, CDKN2A, COL11A2, CRYGD, DHX8, EPHA3, ERBB2, ERCC4, FANCA, FAP, RAD52, HRAS, HSD11B2, HSD17B1, IGFBP4, KIT, MFAP1, MSH3, NF2, NOTCH3, NRAS, APC, LOC111589215
-
Viral Disease
Wikipedia
. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj bk bl bm bn bo bp bq br bs bt bu bv bw bx by bz ca cb cc cd ce cf cg ch ci cj ck cl cm cn co cp cq cr cs ct cu cv cw cx cy cz da db dc dd de df dg dh di dj dk dl dm dn do dp dq dr ds dt du dv dw dx dy dz ea eb ec ed ee ef eg eh ei ej ek el em en eo ep eq er es et eu ev ew ex ey ez fa fb fc fd fe ff fg fh fi fj fk fl fm fn fo fp fq fr fs ft fu fv fw fx fy fz ga gb gc gd ge gf gg gh gi Fisher, Bruce; Harvey, Richard P.; Champe, Pamela C. (2007). ... Retrieved 7 September 2020 . ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am Table 1 in: Dimitrov, Dimiter S. (2004). ... "Isolation of a novel species of flavivirus and a new strain of Culex flavivirus (Flaviviridae) from a natural mosquito population in Uganda" . Journal of General Virology . 90 (11): 2669–78. doi : 10.1099/vir.0.014183-0 . ... "Hand, foot, and mouth disease: Identifying and managing an acute viral syndrome" . Cleve Clin J Med . 81 (9): 537–43. doi : 10.3949/ccjm.81a.13132 .